CN Patent

CN115160402A — 结晶盐形式

Assigned to Stealth Biotherapeutics Corp · Expires 2022-10-11 · 4y expired

What this patent protects

本发明涉及结晶盐形式。具体而言，本发明公开了D‑Arg‑Dmt‑Lys‑Phe‑NH 2 的各种结晶盐形式。

USPTO Abstract

本发明涉及结晶盐形式。具体而言，本发明公开了D‑Arg‑Dmt‑Lys‑Phe‑NH 2 的各种结晶盐形式。

Drugs covered by this patent

elamipretide-hydrochloride (ELAMIPRETIDE HYDROCHLORIDE)

Patent Metadata

Patent number: CN115160402A
Jurisdiction: CN
Classification: —
Expires: 2022-10-11
Drug substance claim: No
Drug product claim: No
Assignee: Stealth Biotherapeutics Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.